Showing results (61-70 of 176) with videos related to
Sort By:
Pageof 18
Clinical Trials (London, England)|September 17, 2015
Data monitoring committees for pragmatic clinical trialsSusan S Ellenberg, Richard Culbertson, Daniel L Gillen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2002
High-resolution scintimammography: a pilot studyRachel F Brem, Joelle M Schoonjans, Douglas A Kieper, et al.American Heart Journal|October 12, 2010
Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart diseaseHarvey White, Claes Held, Ralph Stewart, et al.Journal of Cardiac Failure|October 14, 2014
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Danielle Wrolstad, George L Bakris, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Strategies to improve healthcare websitesConstance Johnson, Susan K Peterson, James P Turley, et al.Therapeutic Innovation & Regulatory Science|September 21, 2018
Responsibilities of Data Monitoring Committees: Consensus RecommendationsBarbara E Bierer, Rebecca Li, Jonathan Seltzer, et al.Food Research International (Ottawa, Ont.)|March 12, 2020
A matter of place: Sensory and chemical characterisation of fine Australian Chardonnay and Shiraz wines of provenanceMarcell Kustos, Joanna M Gambetta, David W Jeffery, et al.Journal of Medical Imaging and Radiation Oncology|August 2, 2019
Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of gliomaTristan B Shaw, Rosalind L Jeffree, Paul Thomas, et al.The New England Journal of Medicine|June 25, 2011
Bardoxolone methyl and kidney function in CKD with type 2 diabetesPablo E Pergola, Philip Raskin, Robert D Toto, et al.Journal of Biopharmaceutical Statistics|October 19, 2012
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample sizeYuan Ji, Lei Feng, Ping Liu, et al.Pageof 18